We are live on ! Find out more
AAP

Ardsley Advisory Partners Portfolio holdings

AUM $960M
1-Year Est. Return 207.76%
This Fund
S&P 500
This Quarter Est. Return
-18.67%
1 Year Est. Return
+207.76%
3 Year Est. Return
+554.53%
5 Year Est. Return
+728.66%
10 Year Est. Return
+4,084.52%
AUM
$412M
AUM Growth
-$384M
Cap. Flow
-$251M
Cap. Flow %
-60.94%
Top 10 Hldgs %
41.13%
Holding
228
New
66
Increased
22
Reduced
39
Closed
83

Top Buys

Rank Stock Value
1
AY
Atlantica Sustainable Infrastructure plc Ordinary Shares
AY
+$23.3M
2
MLNX
Mellanox Technologies, Ltd.
MLNX
+$15.3M
3
AKRX
Akorn Inc
AKRX
+$9.65M
4
BIS icon
ProShares UltraShort NASDAQ Biotechnology
BIS
+$9.31M
5
SEDG icon
SolarEdge
SEDG
+$7M

Top Sells

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$77.1M
2
SCTY
SolarCity Corporation
SCTY
+$31.9M
3
MET icon
MetLife
MET
+$20M
4
GILD icon
Gilead Sciences
GILD
+$19.4M
5
CELG
Celgene Corp
CELG
+$17.8M

Sector Composition

Rank Sector Weight
1 Healthcare 17.1%
2 Technology 15.69%
3 Real Estate 11.85%
4 Consumer Discretionary 7.19%
5 Financials 5.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ADXS
126
DELISTED
Advaxis Inc
ADXS
$206K 0.05%
+1,340
New +$324K
AMZN icon
127
Amazon
AMZN
$2.48T
$205K 0.05%
8,000
-2,000
-20% -$50.6K
SHPG
128
DELISTED
Shire pic
SHPG
$205K 0.05%
+1,000
New +$238K
CDXS icon
129
Codexis
CDXS
$161M
$203K 0.05%
60,000
+35,000
+140% +$131K
ATML
130
DELISTED
ATMEL CORP
ATML
$202K 0.05%
+25,000
New +$207K
AKRX
131
CALL
DELISTED
Akorn Inc
AKRX
$200K 0.05%
+7,000
New +$289K
CORV
132
DELISTED
Correvio Pharma Corp. Ordinary Shares (Canada)
CORV
$197K 0.05%
23,400
– –
SRI icon
133
Stoneridge
SRI
$208M
$185K 0.04%
+15,000
New +$178K
CVV icon
134
CVD Equipment Corp
CVV
$46.7M
$165K 0.04%
+15,000
New +$167K
AGTC
135
DELISTED
Applied Genetic Technologies Corporation
AGTC
$164K 0.04%
12,467
– –
CERS icon
136
Cerus
CERS
$585M
$159K 0.04%
+35,000
New +$181K
MTLS
137
Materialise
MTLS
$373M
$154K 0.04%
20,000
-15,000
-43% -$128K
VYNT
138
DELISTED
Vyant Bio, Inc. Common Stock
VYNT
$117K 0.03%
100
-167
-63% -$256K
STRM
139
DELISTED
Streamline Health Solutions
STRM
$115K 0.03%
3,333
– –
SAAS
140
DELISTED
inContact, Inc.
SAAS
$111K 0.03%
+15,000
New +$124K
RELY
141
DELISTED
Real Industry, Inc.
RELY
$88K 0.02%
+10,000
New +$106K
EPRS
142
DELISTED
EPIRUS BIOPHARMACEUTICALS INC COM
EPRS
$66K 0.02%
15,000
-10,000
-40% -$58.7K
LCTX icon
143
Lineage Cell Therapeutics
LCTX
$267M
$45K 0.01%
18,585
– –
XOMA
144
DELISTED
Xoma
XOMA
$23K 0.01%
1,500
-3,250
-68% -$103K
ALIM
145
DELISTED
Alimera Sciences
ALIM
$22K 0.01%
667
– –
A icon
146
Agilent Technologies
A
$39.7B
– –
-7,500
Closed -$289K
AMC icon
147
AMC Entertainment Holdings
AMC
$2.38B
– –
-1,000
Closed -$307K
BDX icon
148
Becton Dickinson
BDX
$45.8B
– –
-5,638
Closed -$779K
BIIB icon
149
Biogen
BIIB
$30.4B
– –
-1,000
Closed -$406K
COR icon
150
Cencora
COR
$62.2B
– –
-112,500
Closed -$12M
4 5
6
7 8

Similar funds

NA
Navellier & Associates Reno, Nevada $960M AUM 79.37% 1-Year Est. Return
MK
MASTERINVEST Kapitalanlage Vienna $962M AUM 27.59% 1-Year Est. Return
QIM
Quantitative Investment Management Charlottesville, Virginia $963M AUM 12.95% 1-Year Est. Return
JVBC
J.V. Bruni & Co Colorado Springs, Colorado $958M AUM 22.2% 1-Year Est. Return
TFP
Triple Frond Partners San Francisco, California $963M AUM 27.45% 1-Year Est. Return
UWPG
Ullmann Wealth Partners Group Jacksonville Beach, Florida $963M AUM 17.06% 1-Year Est. Return
LOAMU
Lombard Odier Asset Management (USA) New York $957M AUM 35.8% 1-Year Est. Return
PHS
Pekin Hardy Strauss Chicago, Illinois $957M AUM 44.61% 1-Year Est. Return

Ardsley Advisory Partners's Q3 2015 Portfolio in Review

As of Q3 2015, Ardsley Advisory Partners held 228 positions worth $412M, down 48% from $797M the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Ardsley Advisory Partners withdrew a net $251M in Q3 2015, closing 83 positions and reducing 39 holdings. Its most notable exit was State Street SPDR S&P 500 ETF Trust, an estimated $77.1M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, down from 21% a quarter earlier, followed by Technology and Real Estate.

Against the trend, Ardsley Advisory Partners opened a new position in Mellanox Technologies, Ltd. worth $13.5M.

  • Ardsley Advisory Partners's largest Q3 2015 buy was Mellanox Technologies, Ltd.: 357,000 shares worth $13.5M.
  • Ardsley Advisory Partners added most to Atlantica Sustainable Infrastructure plc Ordinary Shares in Q3 2015, an estimated $23.3M increase.
  • Ardsley Advisory Partners's biggest Q3 2015 reduction was MetLife, cutting an estimated $20M.
  • Ardsley Advisory Partners fully exited State Street SPDR S&P 500 ETF Trust in Q3 2015, selling an estimated $77.1M.
  • Ardsley Advisory Partners's ten largest holdings make up 41% of its $412M portfolio in Q3 2015.
  • Ardsley Advisory Partners opened 66 new positions and closed 83 in Q3 2015.
  • Ardsley Advisory Partners's portfolio value fell 48% quarter-over-quarter to $412M.

Based on Ardsley Advisory Partners's 13F filing for Q3 2015, filed 16 Nov 2015.